New Biomarkers Offer Hope for Earlier Autism Identification

Eye-Tracking and Digital Phenotyping Show Potential

Eye-tracking technology offers a non-invasive approach to identifying autism-related traits. A JAMA Network Open study (N=1,089 children) found composite eye-tracking measures could help flag autism in primary care settings. However, as noted in Frontiers in Psychiatry, these tools require validation across diverse populations before widespread use.

Digital phenotyping—analyzing movement and interaction patterns—has shown scalability. A Nature Medicine study demonstrated AI could detect potential cases, though researchers caution this shouldn't replace comprehensive evaluation.

Microbial Metabolites and Stool Tests: Preliminary Findings

A Nature study identified distinct microbial metabolites in some autistic children's urine. While intriguing, the study involved only 162 participants and may apply to specific subgroups. As The New York Times reported, such biomarkers require replication in larger cohorts.

An AI-powered stool test, designated breakthrough by the FDA, is being piloted in Hong Kong (MobiHealthNews). While developers claim 95% accuracy, these figures come from press releases, not peer-reviewed data.

Toward Balanced Implementation

As Cureus notes, early identification must balance potential benefits with risks like overdiagnosis. These tools could complement—but not replace—current standards like the M-CHAT.

Autistic self-advocates emphasize that identification should serve support needs, not just early intervention. As research progresses, maintaining scientific rigor while respecting neurodiversity remains paramount.